Sklice clinical trial results published

Created on 26.04.12

An updated version of the FDA-approved Sklice clinical trial has been published on the website.

The Sklice trial was a Pharmacokinetics (PK) study of lice-infected children between 6 months and 3 years of age, using 0.5% Ivermectin cream combined with standard pharmacokinetic outcome measures to determine overall safety. Summary results are published at, and a more detailed version of the FDA review can be found here.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 — all rights reserved